Provided by Tiger Trade Technology Pte. Ltd.

Insmed

147.60
-0.7100-0.48%
Post-market: 146.95-0.6500-0.44%18:12 EDT
Volume:2.59M
Turnover:383.61M
Market Cap:31.82B
PE:-22.99
High:149.88
Open:148.45
Low:146.26
Close:148.31
52wk High:212.75
52wk Low:60.40
Shares:215.55M
Float Shares:193.00M
Volume Ratio:0.84
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4200
EPS(LYR):-6.4200
ROE:-249.28%
ROA:-28.99%
PB:43.05
PE(LYR):-22.99

Loading ...

Insmed Inc - Arikayce Global Revenues $433.8 Mln for 2025

THOMSON REUTERS
·
Jan 09

Insmed’s Top Brass Quietly Cashes In on a Multi-Million Dollar Stock Windfall

TIPRANKS
·
Jan 09

Insmed COO Roger Adsett Reports Sale of Common Shares

Reuters
·
Jan 09

Insmed CFO Sara Bonstein Reports Sale of Common Shares

Reuters
·
Jan 09

Insmed Chief Medical Officer Martina Flammer Reports Sale of Common Shares

Reuters
·
Jan 09

Insmed Inc. Chief Legal Officer Michael Alexander Smith Reports Sale of Common Shares

Reuters
·
Jan 09

Insmed price target lowered to $157 from $158 at Morgan Stanley

TIPRANKS
·
Jan 08

RBC Lifts Price Target on Insmed to $197 From $195, Keeps Outperform Rating

MT Newswires Live
·
Jan 08

Insmed Is Maintained at Buy by UBS

Dow Jones
·
Jan 07

UBS Adjusts Price Target on Insmed to $215 From $223, Maintains Buy Rating

MT Newswires Live
·
Jan 07

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EST on 2026-01-05

Reuters
·
Jan 06

Insmed to Present at J.P. Morgan Healthcare Conference

Reuters
·
Jan 02

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2025-12-31

Reuters
·
Jan 01

S&P 500 Futures Flat In Premarket Trading; Regencell Bioscience, AngloGold Ashanti Lead

Dow Jones
·
Dec 30, 2025

Insmed (INSM) Valuation Check After BiRCh Trial Setback and Respiratory Pipeline Shift

Simply Wall St.
·
Dec 24, 2025

Nike, Insmed, And Arm Are Among Top 10 Large Cap Losers Last Week (Dec. 15-Dec. 19): Are the Others in Your Portfolio?

Benzinga
·
Dec 21, 2025

Insmed Inc. Chair and CEO William Lewis Reports Disposal of Common Shares

Reuters
·
Dec 20, 2025

Insmed Inc : Truist Securities Cuts Target Price to $205 From $214

THOMSON REUTERS
·
Dec 19, 2025

Insmed Inc : Truist Securities Assumes Coverage With Buy Rating; Target Price $205 VS $214

THOMSON REUTERS
·
Dec 19, 2025

Why Is Insmed Stock Falling Thursday?

Benzinga
·
Dec 19, 2025